Histopathologic evaluation demonstrated a CD5-positive large B-cell lymphoma with a markedly elevated proliferative index and no evidence of double-hit or triple-hit lymphoma on fluorescence in situ hybridization. The gene discussed is CD5; the disease is B-cell non-Hodgkin lymphoma.